DEPARTMENT OF JUSTICE SUBPOENAS DOCUMENTS FROM GLAXOSMITHKLINE OVER ITS MARKETING OF AVANDIA | Dallas, Texas Personal Injury Attorney Blog
Avandia Angst: GlaxoSmithKline said it is responding to a U.S. Department of Justice subpoena and also to civil investigative demands” from “a number” of state attorneys general dealing with how the company developed and marketed the diabetes drug Avandia, the WSJ reports. (Its not clear whether the DOJ’s request relates to a civil or criminal probe.)
The disclosure came in GSK’s third-quarter earnings announcement, which showed a 3.5% drop in net profit. In September the FDA put additional restrictions on the use of the drug, while European regulators pulled it from the market.
Montes Law Group, P.C.
Attorneys: Rachel Montes
1121 Kinwest Parkway, Suite 100
Irving, Texas 75063
Telephone (214) 522-9401
Toll Free (877) 529-8899
Facebook @ Montes Law Group, P.C.
I think this is among the most important info for me. And i’m enjoying reading your article. cheers